Form 4: VNRX Officer's RSU Tax Withholding

VolitionRx's Group Chief Marketing Officer, Ann-Louise Batchelor, had 8,620 shares withheld for tax obligations related to restricted stock unit settlement.

Summary

• Ann-Louise Batchelor, Group Chief Marketing Officer of VolitionRx Ltd (VNRX), reported a disposition of 8,620 shares of common stock.
• The transaction occurred on August 1, 2025, and was coded as 'F', indicating a disposition to the issuer to satisfy tax withholding obligations.
• These shares were withheld by VolitionRx for cancellation to cover tax liabilities arising from the settlement of 18,341 restricted stock units (RSUs).
• The RSUs were awarded to Ms. Batchelor in lieu of cash compensation.
• No shares were sold by either Ms. Batchelor or VolitionRx in this transaction.
• Following this transaction, Ms. Batchelor directly owns 132,486 shares and indirectly owns 29,406 shares through her spouse.
• The shares were valued at $0.64 for the purpose of tax withholding.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The transaction is a routine tax withholding event related to equity compensation, indicating the officer is receiving benefits. It's not a sale by the officer, which is generally viewed more favorably than a direct sale.

Positives

• The transaction represents the settlement of restricted stock units, indicating compensation for the officer.
• No actual sale of shares by the officer or the company occurred, meaning no direct market selling pressure from this specific transaction.

Negatives

• A reduction in the officer's direct beneficial ownership by 8,620 shares due to tax withholding.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This filing is a routine insider transaction related to equity compensation and does not provide broader industry context or trends.

Related Party Transactions

• The transaction stems from the settlement of restricted stock units awarded to the Group Chief Marketing Officer, which is a form of related party compensation.

Stakeholder Impact

• Shareholders: This routine transaction has minimal direct impact on shareholders, as it represents a standard tax withholding event rather than a market sale.
• Employees: Reflects the company's standard practice of providing equity compensation to its executives.

Key Dates

Recommendation

This Form 4 filing details a routine tax withholding event related to the settlement of restricted stock units for a company officer. It does not indicate any change in the company's fundamentals, strategic direction, or financial performance. As such, it provides no new information that would warrant a change in an existing investment thesis. The transaction is a standard part of executive compensation and does not suggest any significant positive or negative implications for the stock price.

Keywords

VolitionRx, VNRX, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Tax Withholding, Equity Compensation, Ann-Louise Batchelor, Officer Compensation